Volcano CE marks imaging system and catheter for coronary imaging
This article was originally published in Clinica
Executive Summary
Vascular diagnostics specialist Volcano has CE marked its OCT (optical coherence tomography) imaging system and catheter for sale in Europe. The product allows physicians to image diseased arteries from the inside to assess lesions. Volcano (San Diego, California) already markets intravascular ultrasound (IVUS) devices for this type of imaging, but OCT produces extremely high-quality three-dimensional images, with higher resolution than other imaging methods like ultrasound. The system could be used for image-guided percutaneous coronary intervention or the evaluation of drug-eluting stents. Volcano plans to launch the OCT system in Europe in 2011, and also hopes to carry out a trial to support US approval this year.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.